Semaglutide-Glycine-Cyanocobalamin Injectable recall (PAYLESS COMPOUNDERS, LLC)
DrugClass IIOngoing
Summary: PAYLESS COMPOUNDERS, LLC is recalling Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR. Reason: Lack of Assurance of Sterility.
What is being recalled
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
Why
Lack of Assurance of Sterility
How serious is it
Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.
Where it was sold
OR
How to tell if yours is affected
Lot Number [email protected]
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0471-2026 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class II |
| Status | Ongoing |
| Recall started | March 6, 2026 |
| Reported | April 22, 2026 |
| Company | PAYLESS COMPOUNDERS, LLC |
| Company location | Beaverton, OR, United States |
| Initiated by | Voluntary: Firm initiated |
| Quantity | 91 vials |
More recalls from PAYLESS COMPOUNDERS, LLC · all drug recalls · recalls from March 2026